Pharmacologic treatment of thalassemia intermedia with hydroxyurea
Authors:
- Howard A. PearsonHPHoward A. Pearson
- 1 September 1994
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 125 (3) , 490-492
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Trial of recombinant human erythropoietin: three patients with thalassemia intermedia [letter]Blood, 1992
- Therapeutic Approaches to Hemoglobin Switching in Treatment of HemoglobinopathiesAnnual Review of Medicine, 1992
- Pharmacologic Manipulation of Fetal HemoglobinAnnals of the New York Academy of Sciences, 1990
- 5‐AZACYTIDINE TREATMENT IN A βo‐THALASSAEMIC PATIENT UNABLE TO BE TRANSFUSED DUE TO MULTIPLE ALLOANTIBODIESBritish Journal of Haematology, 1989
- alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adultBlood, 1988
- Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or HydroxyureaNew England Journal of Medicine, 1985
- 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+ThalassemiaNew England Journal of Medicine, 1982